
BioNTech
OrganizationHeard in 13 episodes across 9 shows since Aug 2026
BioNTech SE is a German biotechnology company that develops mRNA-based medicines and vaccines, including oncology immunotherapies and infectious-disease vaccines.
Episodes
This week
Expert statements
Share of the conversation
Mentions of BioNTech per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 28 | 0.03‰ | 3 |
| Aug 30 | 0.05‰ | 2 |
| Sep 13 | 0.01‰ | 1 |
| Sep 14 | 0.02‰ | 1 |
| Oct 9 | 0.01‰ | 1 |
| Oct 12 | 0.02‰ | 1 |
| Oct 16 | 0.02‰ | 1 |
| Oct 22 | 0.02‰ | 1 |
| Oct 26 | 0.02‰ | 1 |
| Oct 30 | 0.03‰ | 3 |
| Nov 17 | 0.01‰ | 1 |
Email alert
Email me when BioNTech comes up on a podcast
One email a week at most, with the new episodes that mention BioNTech. Free, no account needed, unsubscribe in one click.
What experts have said about BioNTech
3 statements · 1 positive · 2 negative
BioNTech and Roche’s neoantigen program has struggled to demonstrate clinical efficacy.
“that has really struggled to show efficacy in the clinic, including as monotherapy plus Keytruda.”
Open the episode · Ep. 398 - J&J’s $2B NewCo Buy, Neoantigen Vaccines, Overton OddsListen at 12:54
BioNTech and Roche’s Phase 3 trial failed its progression-free-survival endpoint.
“that failed to meet its progression-free survival endpoint.”
Open the episode · Ep. 398 - J&J’s $2B NewCo Buy, Neoantigen Vaccines, Overton OddsListen at 13:15
BioNTech is a good company or investment.
“I think you got a good one.”
Open the episode · Mad Money w/ Jim Cramer 8/26/26Listen at 36:04
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
13 episodes featuring BioNTech, newest first
- Nov 17, 2026
Biotech bets meet a pivotal FDA succession fightBioCentury This WeekNov 17, 2026 - Oct 30, 2026
Biotech weighs AI promise against biology’s stubborn bottlenecksBiotech HangoutOct 30, 2026 - Oct 26, 2026
Meta seeks AI funding as Tesla rides SpaceX speculationStock MoversOct 26, 2026 - Oct 22, 2026
AI Sell-Off Tests Tech’s Growth StoryCNBC's "Fast Money"Oct 22, 2026 - Oct 16, 2026
Biotech selloff tests valuations as clinical bets advanceBiotech HangoutOct 16, 2026 - Oct 12, 2026
Biotech investors weigh AI, China, and clinical executionBusiness Of BiotechOct 12, 2026